Micronics

Redmond, United States Founded: 1996 • Age: 30 yrs Acquired By Sony
Point-of-care microfluidics devices for rapid testing

About Micronics

Micronics is a Healthcare company based in Redmond (United States) founded in 1996, and was acquired by Sony in September 2011. Point-of-care microfluidics devices for rapid testing. Micronics has raised $9 million across 2 funding rounds from investors including Sony India. The company has 35 employees. The company was acqui-hired. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Diversified. Its legal entity is Micronics, Inc. Its competitors include Inflammatix, Karius and Visby Medical; 3 of its 3 listed competitors have raised funding.

Company details

Micronics develops point-of-care microfluidics devices for rapid testing. Its proprietary platform allows clinicians to perform assays on credit-card sized disposable cartridges. Micronics instruments support various testing modalities, including immunoassays, nucleic acid assays, protein crystallography and DNA sequencing. First focus is point-of-care testing for infectious diseases.

  • Headquarters Redmond, United States
  • Employees 35
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website micronics.net
  • Social LinkedIn
  • Acquired by Sony (Sep 2011)
  • Legal Name Micronics, Inc.
Operational Areas
Key Metrics
  • Total Equity Funding
    $9M (USD)

    in 2 rounds

  • Latest Funding Round
    $2.6M (USD), Grant

    Oct 2010

  • Investors
  • Employee Count
    35
  • Acquired by
    Sony

    (Sep 2011)

Funding Insights of Micronics

Micronics has successfully raised a total of $9M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $2.6 million completed in October 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $9M
  • Total Rounds 2
  • Last Round Grant β€” $2.6M
  • First Round $9M

    (Oct 2008)

All 2 funding rounds of Micronics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2010$2.6MGrant––
–
Oct 2008$9MSeries C––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Micronics

Micronics has secured backing from 1 investor. Prominent investors backing the company include Sony India.

All
InvestorDescriptionFounded YearDomainLocation
Sony India is engaged in manufacturing and selling consumer electronics.
sony.co.inIndia
Premium access

Investor details for Micronics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Micronics

4 dated milestones of Micronics across 15 years, from founding to its latest funding, stage changes and deals.

  1. Founded Micronics is founded.
  2. Funding First funding round of $9.0M.
  3. Funding Latest funding round, Grant, of $2.6M.
  4. Exit Acquired by Sony.

Competitors of Micronics

Micronics has 3 listed competitors in our database, 3 of them funded. They include Inflammatix, Karius and Visby Medical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
inflammatix.com2016San Francisco, United States$191.47M54
Provider of diagnostic solutions for systemic infections
kariusdx.com2014Redwood, United States$315M139
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
visbymedical.com2010San Jose, United States$386.33M251
Portable PCR diagnostics for infectious diseases are developed.
Premium access

Detailed competitors of Micronics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Micronics

Websites that share an audience with Micronics (micronics.net).

Similar websites

Websites whose visitors overlap most with Micronics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
csem.ch
100%
55.2K#640,194View details
memsurface.com
memsurface.com
100%
–
memscap.com
100%
4.2K#4,291,585View details
coventor.com
100%
View details
sporian.com
100%
View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 20 similar websites and full traffic analytics for Micronics

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 20 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Infectious Diseases

3 companies that operate in the same segment as Micronics (Infectious Diseases) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Therapeutics for drug-resistant bacterial infections are developed.
2013Cambridge, Massachusetts, United StatesUSD 114.7 MUSD 59.62 M32
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Micronics

Premium access

Complete news archive for Micronics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Micronics

Micronics was founded in 1996 and raised its 1st funding round 12 years after it was founded.

Micronics is headquartered in Redmond, United States. It is registered at Redmond, Washington, United States.

Micronics is a funded company, having raised a total of $9M across 2 funding rounds to date. The company's 1st funding round was a Series C of $9M, raised on Oct 2008.

Micronics has 35 employees.

Micronics develops point-of-care microfluidics devices for rapid testing. Its proprietary platform allows clinicians to perform assays on credit-card sized disposable cartridges. Micronics instruments support various testing modalities, including immunoassays, nucleic acid assays, protein crystallography and DNA sequencing. First focus is point-of-care testing for infectious diseases.

Micronics's top competitors include Visby Medical, Inflammatix and Karius.

Micronics has 1 investor. Key investors include Sony India.

Micronics operates through Micronics, Inc..

Yes. Micronics was acquired by Sony in September 2011.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available